Hadar Goldvaser, Salome Khutsurauli, Michèle Buchinger, Anton Safonov, Albert Grinshpun. "Oral estrogen receptor (ER) degraders compared to standard endocrine therapy (ET) in ER-positive, human epidermal growth factor receptor 2 (HER2)–negative metastatic breast cancer (MBC): A systematic review and meta-analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1087